Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengquan Shen

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Archives of Medical Research|December 17, 2022
Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical CarcinomaChengquan Shen, Yonghua Wang
Frontiers in Endocrinology|March 11, 2021
Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical CarcinomaChengquan Shen, Jing Liu, Xiaokun Yang, et al.
Cancer Cell International|December 9, 2020
Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancerChengquan Shen, Jing Liu, Liping Wang, et al.
International Immunopharmacology|November 15, 2020
Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancerJirong Wang, Chengquan Shen, Dahai Dong, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 15, 2025
Tumor-intrinsic ENO1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD-L1 immunotherapy in bladder cancerChengquan Shen, Jing Liu, Ding Hu, et al.
Disease Markers|May 27, 2020
The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGAChengquan Shen, Jing Liu, Jirong Wang, et al.
Cell Cycle (Georgetown, Tex.)|December 7, 2022
High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancerXuezhou Zhang, Jing Liu, Xuecheng Yang, et al.
International Immunopharmacology|February 12, 2020
Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinomaChengquan Shen, Jing Liu, Jirong Wang, et al.
Cell Death & Disease|November 18, 2024
NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathwayChangxue Liu, Huaixi Ge, Chengquan Shen, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2023
A feed-forward loop based on aerobic glycolysis and TGF-β between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escapeChengquan Shen, Jing Liu, Wei Jiao, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Archives of Medical Research|December 17, 2022
Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical CarcinomaChengquan Shen, Yonghua Wang
Frontiers in Endocrinology|March 11, 2021
Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical CarcinomaChengquan Shen, Jing Liu, Xiaokun Yang, et al.
Cancer Cell International|December 9, 2020
Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancerChengquan Shen, Jing Liu, Liping Wang, et al.
International Immunopharmacology|November 15, 2020
Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancerJirong Wang, Chengquan Shen, Dahai Dong, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 15, 2025
Tumor-intrinsic ENO1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD-L1 immunotherapy in bladder cancerChengquan Shen, Jing Liu, Ding Hu, et al.
Disease Markers|May 27, 2020
The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGAChengquan Shen, Jing Liu, Jirong Wang, et al.
Cell Cycle (Georgetown, Tex.)|December 7, 2022
High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancerXuezhou Zhang, Jing Liu, Xuecheng Yang, et al.
International Immunopharmacology|February 12, 2020
Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinomaChengquan Shen, Jing Liu, Jirong Wang, et al.
Cell Death & Disease|November 18, 2024
NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K/AKT pathwayChangxue Liu, Huaixi Ge, Chengquan Shen, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2023
A feed-forward loop based on aerobic glycolysis and TGF-β between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escapeChengquan Shen, Jing Liu, Wei Jiao, et al.
Pageof 2